Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 4
2006 1
2010 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
The epithelial-mesenchymal transition (EMT) and colorectal cancer progression.
Bates RC, Mercurio AM. Bates RC, et al. Cancer Biol Ther. 2005 Apr;4(4):365-70. doi: 10.4161/cbt.4.4.1655. Epub 2005 Apr 4. Cancer Biol Ther. 2005. PMID: 15846061 Review.
IAP regulation of metastasis.
Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. Mehrotra S, et al. Cancer Cell. 2010 Jan 19;17(1):53-64. doi: 10.1016/j.ccr.2009.11.021. Cancer Cell. 2010. PMID: 20129247 Free PMC article.
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.
Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM, Mercurio AM. Mak P, et al. Cancer Cell. 2010 Apr 13;17(4):319-32. doi: 10.1016/j.ccr.2010.02.030. Cancer Cell. 2010. PMID: 20385358 Free PMC article.
Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition.
Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. Bachelder RE, et al. J Cell Biol. 2005 Jan 3;168(1):29-33. doi: 10.1083/jcb.200409067. J Cell Biol. 2005. PMID: 15631989 Free PMC article.
The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis.
Bates RC, DeLeo MJ 3rd, Mercurio AM. Bates RC, et al. Exp Cell Res. 2004 Oct 1;299(2):315-24. doi: 10.1016/j.yexcr.2004.05.033. Exp Cell Res. 2004. PMID: 15350531
Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.
Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H, Sheppard D, Oettgen P, Mercurio AM. Bates RC, et al. J Clin Invest. 2005 Feb;115(2):339-47. doi: 10.1172/JCI23183. J Clin Invest. 2005. PMID: 15668738 Free PMC article.
Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
Bellovin DI, Simpson KJ, Danilov T, Maynard E, Rimm DL, Oettgen P, Mercurio AM. Bellovin DI, et al. Oncogene. 2006 Nov 2;25(52):6959-67. doi: 10.1038/sj.onc.1209682. Epub 2006 May 22. Oncogene. 2006. PMID: 16715134 Free article.
Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease.
Bellovin DI, Bates RC, Muzikansky A, Rimm DL, Mercurio AM. Bellovin DI, et al. Cancer Res. 2005 Dec 1;65(23):10938-45. doi: 10.1158/0008-5472.CAN-05-1947. Cancer Res. 2005. PMID: 16322241 Free article.